Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 2510-2514, June 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X. Q.
Right arrow Articles by Ellem, K. A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X. Q.
Right arrow Articles by Ellem, K. A. O.

Accumulation of p16CDKN2A in Response to Ultraviolet Irradiation Correlates with a Late S-G2-Phase Cell Cycle Delay1

Xue Qing Wang, Brian G. Gabrielli2, Amanda Milligan, Joanne L. Dickinson, Toni M. Antalis and Kay A. O. Ellem

Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, The Bancroft Center, P. O. Royal Brisbane Hospital, Brisbane 4029, Queensland, Australia

p16 is the product of the CDKN2A locus, which is mutated or deleted in many human tumors. In response to nonlethal UVC irradiation, HeLa cells accumulate elevated levels of p16. The accumulation of p16 is delayed 8–12 h following irradiation and correlates with S-phase and G2 delays, decreasing as the cells recover and recommence normal cell growth. The maximum levels of p16 correlated with G2 delay. The UVC-induced cell cycle delay was absent in cell lines derived from HeLa that did not express p16 and in a melanoma line deleted for p16.

1 This work was supported by grants from the National Health and Medical Research Council and the Queensland Cancer Fund. B. G. is a Fuiczek Fellowship holder.

2 To whom requests for reprints should be addressed. Fax: (07) 3362 0107; E-mail brianG@qimr.edu.au.

Received 3/ 4/96. Accepted 4/17/96.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
H. Harada, H. Nakagawa, K. Oyama, M. Takaoka, C. D. Andl, B. Jacobmeier, A. von Werder, G. H. Enders, O. G. Opitz, and A. K. Rustgi
Telomerase Induces Immortalization of Human Esophageal Keratinocytes Without p16INK4a Inactivation
Mol. Cancer Res., August 1, 2003; 1(10): 729 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Harding, N. Giles, A. Burgess, J. F. Hancock, and B. G. Gabrielli
Mechanism of Mitosis-specific Activation of MEK1
J. Biol. Chem., May 2, 2003; 278(19): 16747 - 16754.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhou, F. G. Gwadry, W. C. Reinhold, L. D. Miller, L. H. Smith, U. Scherf, E. T. Liu, K. W. Kohn, Y. Pommier, and J. N. Weinstein
Transcriptional Regulation of Mitotic Genes by Camptothecin-induced DNA Damage: Microarray Analysis of Dose- and Time-dependent Effects
Cancer Res., March 1, 2002; 62(6): 1688 - 1695.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Pavey and B. Gabrielli
{alpha}-Melanocyte Stimulating Hormone Potentiates p16/CDKN2A Expression in Human Skin after Ultraviolet Irradiation
Cancer Res., February 1, 2002; 62(3): 875 - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Schraml, K. Struckmann, R. Bednar, W. Fu, T. Gasser, K. Wilber, J. Kononen, G. Sauter, M. J. Mihatsch, and H. Moch
CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas : Evidence for a Second Tumor Suppressor Gene Proximal to CDKN2A
Am. J. Pathol., February 1, 2001; 158(2): 593 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Nasu, H. Kohsaka, Y. Nonomura, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka
Adenoviral Transfer of Cyclin-Dependent Kinase Inhibitor Genes Suppresses Collagen-Induced Arthritis in Mice
J. Immunol., December 15, 2000; 165(12): 7246 - 7252.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. Soufir, L. Daya-Grosjean, P. de La Salmoniere, J.-P. Moles, L. Dubertret, A. Sarasin, and N. Basset-Seguin
Association Between INK4a-ARF and p53 Mutations in Skin Carcinomas of Xeroderma Pigmentosum Patients
J Natl Cancer Inst, November 15, 2000; 92(22): 1841 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Bordignon and L. C. Smith
Ultraviolet-Irradiated Spermatozoa Activate Oocytes but Arrest Preimplantation Development After Fertilization and Nuclear Transplantation in Cattle
Biol Reprod, December 1, 1999; 61(6): 1513 - 1520.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark
Mechanisms of G2 Arrest in Response to Overexpression of p53
Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Pavey, S. Conroy, T. Russell, and B. Gabrielli
Ultraviolet Radiation Induces p16CDKN2A Expression in Human Skin
Cancer Res., September 1, 1999; 59(17): 4185 - 4189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. G. Gabrielli, B. Sarcevic, J. Sinnamon, G. Walker, M. Castellano, X.-Q. Wang, and K. A. O. Ellem
A Cyclin D-Cdk4 Activity Required for G2 Phase Cell Cycle Progression Is Inhibited in Ultraviolet Radiation-induced G2 Phase Delay
J. Biol. Chem., May 14, 1999; 274(20): 13961 - 13969.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. T. Lee, P. Capodieci, I. Osman, M. Fazzari, J. Ferrara, H. I. Scher, and C. Cordon-Cardo
Overexpression of the Cyclin-dependent Kinase Inhibitor p16 Is Associated with Tumor Recurrence in Human Prostate Cancer
Clin. Cancer Res., May 1, 1999; 5(5): 977 - 983.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.